Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean F Wong

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
Neuroimage|April 22, 2010
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMARDean F Wong, Hiroto Kuwabara, Andrew G Horti, et al.
Acta Neuropathologica|August 7, 2012
Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaquesIra Driscoll, Juan C Troncoso, Gay Rudow, et al.
Neurobiology of Disease|May 18, 2017
Molecular imaging of serotonin degeneration in mild cognitive impairmentGwenn S Smith, Frederick S Barrett, Jin Hui Joo, et al.
Journal of Biomedical Optics|April 11, 2017
Listening to membrane potential: photoacoustic voltage-sensitive dye recordingHaichong K Zhang, Ping Yan, Jeeun Kang, et al.
JACC. Cardiovascular Imaging|February 8, 2018
Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational ApproachInes Valenta, Zoltan V Varga, Heather Valentine, et al.
Journal of Medicinal Chemistry|August 9, 2016
Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 ReceptorRareş-Petru Moldovan, Rodrigo Teodoro, Yongjun Gao, et al.
Annals of Neurology|June 22, 2022
Associations of Vascular Risk and Amyloid Burden with Subsequent DementiaRebecca F Gottesman, Aozhou Wu, Josef Coresh, et al.
Frontiers in Neuroscience|August 27, 2019
Transcranial Recording of Electrophysiological Neural Activity in the Rodent Brain <i>in vivo</i> Using Functional Photoacoustic Imaging of Near-Infrared Voltage-Sensitive DyeJeeun Kang, Haichong K Zhang, Shilpa D Kadam, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2003
First do no harm: managing antihistamine impairment in patients with allergic rhinitisThomas B Casale, Michael S Blaiss, Erwin Gelfand, et al.
Molecular Imaging and Biology|October 10, 2014
Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) MiceJongho Kim, Andrew G Horti, William B Mathews, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
Neuroimage|April 22, 2010
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [11C]OMARDean F Wong, Hiroto Kuwabara, Andrew G Horti, et al.
Acta Neuropathologica|August 7, 2012
Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaquesIra Driscoll, Juan C Troncoso, Gay Rudow, et al.
Neurobiology of Disease|May 18, 2017
Molecular imaging of serotonin degeneration in mild cognitive impairmentGwenn S Smith, Frederick S Barrett, Jin Hui Joo, et al.
Journal of Biomedical Optics|April 11, 2017
Listening to membrane potential: photoacoustic voltage-sensitive dye recordingHaichong K Zhang, Ping Yan, Jeeun Kang, et al.
JACC. Cardiovascular Imaging|February 8, 2018
Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational ApproachInes Valenta, Zoltan V Varga, Heather Valentine, et al.
Journal of Medicinal Chemistry|August 9, 2016
Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 ReceptorRareş-Petru Moldovan, Rodrigo Teodoro, Yongjun Gao, et al.
Annals of Neurology|June 22, 2022
Associations of Vascular Risk and Amyloid Burden with Subsequent DementiaRebecca F Gottesman, Aozhou Wu, Josef Coresh, et al.
Frontiers in Neuroscience|August 27, 2019
Transcranial Recording of Electrophysiological Neural Activity in the Rodent Brain <i>in vivo</i> Using Functional Photoacoustic Imaging of Near-Infrared Voltage-Sensitive DyeJeeun Kang, Haichong K Zhang, Shilpa D Kadam, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2003
First do no harm: managing antihistamine impairment in patients with allergic rhinitisThomas B Casale, Michael S Blaiss, Erwin Gelfand, et al.
Molecular Imaging and Biology|October 10, 2014
Quantitative Multi-modal Brain Autoradiography of Glutamatergic, Dopaminergic, Cannabinoid, and Nicotinic Receptors in Mutant Disrupted-In-Schizophrenia-1 (DISC1) MiceJongho Kim, Andrew G Horti, William B Mathews, et al.
Pageof 24